anti-IFNγ monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-IFNγ monoclonal antibody, covering 2020-09-04 to 2020-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis [Phase 2, Phase 3]